Brief: Graphite Bio Reports Q2 2021 Financial Results

LENZ Therapeutics

12/08/2021 23:11

Aug 12 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND SECOND
QUARTER
2021 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $3.45
    * AS OF JUNE 30, 2021, CASH, CASH EQUIVALENTS AND RESTRICTED
CASH
TOTALED $382.1 MILLION

Source text for Eikon:  ID:nBw5FyS8Za 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))